News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  2nd October 2012  
  IMCB Turns 25
 
 



On 2nd October 2012, IMCB celebrates its 25th Anniversary. Officially opened on 2nd October 1987 on the NUS campus, IMCB moved to the Biopolis in June 2004 and at the same time, merged with the former Institute of Molecular Agrobiology (IMA).

Today, IMCB remains a premier biomedical research institute in Biopolis with medical and industrial relevance to A*STAR’s mission.

We highlight here some of our scientific achievements and key areas of contribution to the biomedical community. (To view more about each category, please click on button image below)


Publications
IMCB continues to engage in high impact research as can be seen in our increase in citations from the figure below:

This year, the two most highly cited papers from Alan Porter’s and Ed Manser’s lab each garnered more than 1,000 citations.
Please see http://www.imcb.a-star.edu.sg/newsarchive/180712a.php and
http://www.imcb.a-star.edu.sg/newsarchive/130712a.php


Photo of Alan Porter & his lab members.


Manpower Training
IMCB has been highly successful in manpower training and many of its former students and postdoctoral fellows are now in Faculty positions at universities as well as lead scientists in many organizations.
Amongst them are Tuck Wah Soong (graduated 1992), now Head of Physiology at NUS; Woon Kiong Chan (graduated 1990), Associate Prof at NUS (Dept of Biological Sciences); Qi Zeng (graduated 1993), Senior PI at IMCB; Bor Luen Tang (1994), Associate Prof at NUS (Biochemistry) and Cynthia Goh, Centre Director of the Lien Centre for Palliative Care, Duke-NUS Graduate Medical School and Senior Consultant and Head of the Department of Palliative Medicine at the National Cancer Centre Singapore.

For a list of our alumni and their current locations, please see http://www.imcb.a-star.edu.sg/php/alumni-gs.php



Awards
IMCB was conferred the 5th Nikkei Asia Prize in the category of Technology Innovation for its role in improving the quality of life in Asia through its outstanding contribution to biotechnology. The award also recognized IMCB’s impressive development into the first major centre of research in Asia1.

1 - "A*STAR - 20 Years of Science and Technology in Singapore"

Several IMCB scientists including Professors Uttam Surana, Yoshiaki Ito, Alan Porter and Kong Peng Lam have won the National Science Award and the Outstanding University Researcher Award (http://www.imcb.a-star.edu.sg/php/awards.php).

Professors Neal and Nancy Copeland were elected to the United States National Academy of Sciences, Jean Paul Thiery was awarded the Légion d'honneur and Philip Ingham was elected Honorary Fellow of the Royal College of Physicians.
               


IMCB Staff have also won awards at the A*STAR Workplan seminars



IMCB PIs Qi Zeng and Lianhui Zhang were also awarded the prestigious ETPL Flagship grants for translational research.



 


Industrial Collaborations & Spin-offs
Even in the early days, IMCB was cognizant of the importance of industrial interaction and we forged collaborations with several companies like Glaxo Wellcome, and spun off GeneSing (to manufacture Glycoferon) and Merlion Pharmaceuticals.

IMCB strives to maintain its record of scientific excellence and to be an integrated and effective entity in the biomedical landscape. A new generation of young scientists is being groomed to maintain IMCB’s vanguard position in the years ahead.

Please click here view the photo gallery